Argenx Se (ARGX) Divestments (2023 - 2025)
Argenx Se (ARGX) posted quarterly Divestments of -$3.5 million for Q4 2025, down 50.09% year-on-year from -$7.1 million in Q4 2024, and up 6.59% on a QoQ basis from -$3.8 million in Q3 2025.
Argenx Se (ARGX) Divestments (2023 - 2025) Analysis & Trends
Argenx Se (ARGX) has reported Divestments for 3 consecutive years, with -$3.5 million the latest figure, recorded in Q4 2025.
- Quarterly Divestments fell 50.09% year-over-year to -$3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.4 million (down 62.09% YoY) and the FY2025 annual result came in at -$12.4 million, down 262.09% from the prior year.
- Divestments climbed to -$3.5 million in Q4 2025 per ARGX's latest filing, from -$3.8 million in the prior quarter.
- Over the last five years, Divestments for ARGX reached as high as -$743000.0 in Q3 2023 and fell as low as -$3.8 million in Q3 2025.
- A 3-year average of -$2.3 million and a median of -$2.1 million in 2024 frame the typical range for Divestments.
- Annual changes were most pronounced in 2024 — Divestments sank 166.62% — and 2025, when it fell 28.74%.
- Year by year, Divestments stood at -$1.8 million in 2023, then tumbled by 31.43% to -$2.4 million in 2024, then tumbled by 50.09% to -$3.5 million in 2025.
- According to Business Quant data, Divestments over the past three periods registered -$3.5 million, -$3.8 million, and -$2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.53 Mn |
| Sep 30, 2025 | -3.78 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -1.52 Mn |
| Mar 31, 2024 | -1.79 Mn |
| Dec 31, 2023 | -1.79 Mn |
| Sep 30, 2023 | -743,000.00 |